Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Where have I heard that before? A validity study of source memory indices from the California Verbal Learning Test - Second edition.

Babicz MA, Sheppard DP, Morgan EE, Paul Woods S.

Clin Neuropsychol. 2019 May 14:1-20. doi: 10.1080/13854046.2019.1613559. [Epub ahead of print]

PMID:
31084399
2.

Effects of trauma, economic hardship, and stress on neurocognition and everyday function in HIV.

Watson CW, Sundermann EE, Hussain MA, Umlauf A, Thames AD, Moore RC, Letendre SL, Jeste DV, Morgan EE, Moore DJ.

Health Psychol. 2019 Jan;38(1):33-42. doi: 10.1037/hea0000688. Epub 2018 Oct 29.

PMID:
30372103
3.

Poor Self-efficacy for Healthcare Provider Interactions Among Individuals with HIV-Associated Neurocognitive Disorders.

Morgan EE, Woods SP, Iudicello JE, Grant I, Villalobos J; HIV Neurobehavioral Research Program (HNRP) Group.

J Clin Psychol Med Settings. 2019 Mar;26(1):13-24. doi: 10.1007/s10880-018-9560-0.

PMID:
29557544
4.

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Vaborbactam and Meropenem Alone and in Combination following Single and Multiple Doses in Healthy Adult Subjects.

Rubino CM, Bhavnani SM, Loutit JS, Morgan EE, White D, Dudley MN, Griffith DC.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02228-17. doi: 10.1128/AAC.02228-17. Print 2018 Apr.

5.

Preconditioning and Postconditioning by Cardiac Glycosides in the Mouse Heart.

Duan Q, Xu Y, Marck PV, Kalisz J, Morgan EE, Pierre SV.

J Cardiovasc Pharmacol. 2018 Feb;71(2):95-103. doi: 10.1097/FJC.0000000000000549.

PMID:
29419572
6.

Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene.

Russo L, Muturi HT, Ghadieh HE, Wisniewski AM, Morgan EE, Quadri SS, Landesberg GP, Siragy HM, Vazquez G, Scalia R, Gupta R, Najjar SM.

Mol Metab. 2018 Mar;9:98-113. doi: 10.1016/j.molmet.2018.01.009. Epub 2018 Jan 31.

7.

Is the Newest Vital Sign a Useful Measure of Health Literacy in HIV Disease?

Kordovski VM, Woods SP, Avci G, Verduzco M, Morgan EE.

J Int Assoc Provid AIDS Care. 2017 Nov/Dec;16(6):595-602. doi: 10.1177/2325957417729753. Epub 2017 Sep 7.

8.

Positional cloning of quantitative trait nucleotides for blood pressure and cardiac QT-interval by targeted CRISPR/Cas9 editing of a novel long non-coding RNA.

Cheng X, Waghulde H, Mell B, Morgan EE, Pruett-Miller SM, Joe B.

PLoS Genet. 2017 Aug 21;13(8):e1006961. doi: 10.1371/journal.pgen.1006961. eCollection 2017 Aug.

9.

Deficient Emotion Processing is Associated with Everyday Functioning Capacity in HIV-associated Neurocognitive Disorder.

Grabyan JM, Morgan EE, Cameron MV, Villalobos J, Grant I, Paul Woods S; HIV Neurobehavioral Research Program (HNRP) Group.

Arch Clin Neuropsychol. 2018 Mar 1;33(2):184-193. doi: 10.1093/arclin/acx058.

10.

Household Everyday Functioning in the Internet Age: Online Shopping and Banking Skills Are Affected in HIV-Associated Neurocognitive Disorders.

Woods SP, Iudicello JE, Morgan EE, Verduzco M, Smith TV, Cushman C; HIV Neurobehavioral Research Program (HNRP) Group.

J Int Neuropsychol Soc. 2017 Aug;23(7):605-615. doi: 10.1017/S1355617717000431. Epub 2017 Jun 19.

11.

Everyday functional ability in HIV and methamphetamine dependence.

Minassian A, Henry BL, Iudicello JE, Morgan EE, Letendre SL, Heaton RK, Perry W; Translational Methamphetamine AIDS Research Center.

Drug Alcohol Depend. 2017 Jun 1;175:60-66. doi: 10.1016/j.drugalcdep.2017.01.035. Epub 2017 Mar 28.

12.

Accelerated and accentuated neurocognitive aging in HIV infection.

Sheppard DP, Iudicello JE, Morgan EE, Kamat R, Clark LR, Avci G, Bondi MW, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

J Neurovirol. 2017 Jun;23(3):492-500. doi: 10.1007/s13365-017-0523-2. Epub 2017 Mar 20.

13.

Does Age Influence the Frequency of Anxiety Symptoms and Disorders in HIV Disease?

Brandt CP, Sheppard DP, Zvolensky MJ, Morgan EE, Atkinson JH, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

J HIV AIDS Soc Serv. 2016;15(4):380-403. doi: 10.1080/15381501.2016.1189865. Epub 2016 Jun 28. No abstract available.

14.

Relic DNA is abundant in soil and obscures estimates of soil microbial diversity.

Carini P, Marsden PJ, Leff JW, Morgan EE, Strickland MS, Fierer N.

Nat Microbiol. 2016 Dec 19;2:16242. doi: 10.1038/nmicrobiol.2016.242.

PMID:
27991881
15.

High temporal variability in airborne bacterial diversity and abundance inside single-family residences.

Emerson JB, Keady PB, Clements N, Morgan EE, Awerbuch J, Miller SL, Fierer N.

Indoor Air. 2017 May;27(3):576-586. doi: 10.1111/ina.12347. Epub 2016 Oct 31.

PMID:
27743387
16.

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of the β-Lactamase Inhibitor Vaborbactam (RPX7009) in Healthy Adult Subjects.

Griffith DC, Loutit JS, Morgan EE, Durso S, Dudley MN.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6326-32. doi: 10.1128/AAC.00568-16. Print 2016 Oct.

17.

Differential roles of caveolin-1 in ouabain-induced Na+/K+-ATPase cardiac signaling and contractility.

Bai Y, Wu J, Li D, Morgan EE, Liu J, Zhao X, Walsh A, Saikumar J, Tinkel J, Joe B, Gupta R, Liu L.

Physiol Genomics. 2016 Oct 1;48(10):739-748. doi: 10.1152/physiolgenomics.00042.2016. Epub 2016 Aug 12.

18.

Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.

Soontornniyomkij V, Kesby JP, Morgan EE, Bischoff-Grethe A, Minassian A, Brown GG, Grant I; Translational Methamphetamine AIDS Research Center (TMARC) Group.

J Neuroimmune Pharmacol. 2016 Sep;11(3):495-510. doi: 10.1007/s11481-016-9699-0. Epub 2016 Aug 2. Review.

19.

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals.

Cooley SA, Paul RH, Fennema-Notestine C, Morgan EE, Vaida F, Deng Q, Chen JA, Letendre S, Ellis R, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Ances BM; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2016 Oct;22(5):607-614. Epub 2016 Mar 28.

20.

Microbial analyses of airborne dust collected from dormitory rooms predict the sex of occupants.

Luongo JC, Barberán A, Hacker-Cary R, Morgan EE, Miller SL, Fierer N.

Indoor Air. 2017 Mar;27(2):338-344. doi: 10.1111/ina.12302. Epub 2016 Apr 16.

PMID:
27018492
21.

Neurobehavioral Disturbances During Acute and Early HIV Infection.

Kamat R, Doyle KL, Iudicello JE, Morgan EE, Morris S, Smith DM, Little SJ, Grant I, Woods SP; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Cogn Behav Neurol. 2016 Mar;29(1):1-10. doi: 10.1097/WNN.0000000000000084.

22.

Health-Related Decision-Making in HIV Disease.

Doyle KL, Woods SP, Morgan EE, Iudicello JE, Cameron MV, Gilbert PE, Beltran J; HIV Neurobehavioral Research Program (HNRP) Group.

J Clin Psychol Med Settings. 2016 Jun;23(2):135-46. doi: 10.1007/s10880-016-9455-x.

23.

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients.

Flume PA, VanDevanter DR, Morgan EE, Dudley MN, Loutit JS, Bell SC, Kerem E, Fischer R, Smyth AR, Aaron SD, Conrad D, Geller DE, Elborn JS.

J Cyst Fibros. 2016 Jul;15(4):495-502. doi: 10.1016/j.jcf.2015.12.004. Epub 2016 Feb 4.

24.

Predictors of Attrition in a Cohort Study of HIV Infection and Methamphetamine Dependence.

Cattie J, Marquine MJ, Bolden KA, Obermeit LC, Morgan EE, Franklin DR, Umlauf A, Beck JM, Atkinson JH, Grant I, Woods SP; TMARC Group.

J Subst Use. 2015;20(6):407-416. Epub 2015 Feb 3.

25.

Health-Related Everyday Functioning in the Internet Age: HIV-Associated Neurocognitive Disorders Disrupt Online Pharmacy and Health Chart Navigation Skills.

Woods SP, Iudicello JE, Morgan EE, Cameron MV, Doyle KL, Smith TV, Cushman C; HIV Neurobehavioral Research Program (HNRP) Group.

Arch Clin Neuropsychol. 2016 Mar;31(2):176-85. doi: 10.1093/arclin/acv090. Epub 2016 Jan 6.

26.

Elevated rates of mild cognitive impairment in HIV disease.

Sheppard DP, Iudicello JE, Bondi MW, Doyle KL, Morgan EE, Massman PJ, Gilbert PE, Woods SP.

J Neurovirol. 2015 Oct;21(5):576-84. doi: 10.1007/s13365-015-0366-7. Epub 2015 Jul 3.

27.

Typologies of positive psychotic symptoms in methamphetamine dependence.

Bousman CA, McKetin R, Burns R, Woods SP, Morgan EE, Atkinson JH, Everall IP, Grant I; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Am J Addict. 2015 Mar;24(2):94-7. doi: 10.1111/ajad.12160.

28.

Time estimation and production in HIV-associated neurocognitive disorders (HAND).

Doyle KL, Morgan EE, Weber E, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

J Int Neuropsychol Soc. 2015 Feb;21(2):175-81. doi: 10.1017/S1355617715000089.

29.

Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases.

Hecker SJ, Reddy KR, Totrov M, Hirst GC, Lomovskaya O, Griffith DC, King P, Tsivkovski R, Sun D, Sabet M, Tarazi Z, Clifton MC, Atkins K, Raymond A, Potts KT, Abendroth J, Boyer SH, Loutit JS, Morgan EE, Durso S, Dudley MN.

J Med Chem. 2015 May 14;58(9):3682-92. doi: 10.1021/acs.jmedchem.5b00127. Epub 2015 Mar 17.

PMID:
25782055
30.

Antiretroviral Non-Adherence is Associated With a Retrieval Profile of Deficits in Verbal Episodic Memory.

Obermeit LC, Morgan EE, Casaletto KB, Grant I, Woods SP; HIV Neurobehavioral Research Program Group.

Clin Neuropsychol. 2015;29(2):197-213. doi: 10.1080/13854046.2015.1018950. Epub 2015 Mar 17.

31.

Habitual prospective memory in HIV disease.

Doyle KL, Weber E, Morgan EE, Loft S, Cushman C, Villalobos J, Johnston E, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

Neuropsychology. 2015 Nov;29(6):909-918. doi: 10.1037/neu0000180. Epub 2015 Mar 2.

32.

Impacts of flood damage on airborne bacteria and fungi in homes after the 2013 Colorado Front Range flood.

Emerson JB, Keady PB, Brewer TE, Clements N, Morgan EE, Awerbuch J, Miller SL, Fierer N.

Environ Sci Technol. 2015 Mar 3;49(5):2675-84. doi: 10.1021/es503845j. Epub 2015 Feb 13.

PMID:
25643125
33.

A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients.

Stuart Elborn J, Geller DE, Conrad D, Aaron SD, Smyth AR, Fischer R, Kerem E, Bell SC, Loutit JS, Dudley MN, Morgan EE, VanDevanter DR, Flume PA.

J Cyst Fibros. 2015 Jul;14(4):507-14. doi: 10.1016/j.jcf.2014.12.013. Epub 2015 Jan 13.

34.

In vivo assessment of arterial stiffness in the isoflurane anesthetized spontaneously hypertensive rat.

Morgan EE, Casabianca AB, Khouri SJ, Kalinoski AL.

Cardiovasc Ultrasound. 2014 Sep 17;12:37. doi: 10.1186/1476-7120-12-37.

35.

Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders.

Casaletto KB, Obermeit L, Morgan EE, Weber E, Franklin DR, Grant I, Woods SP; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Addict Behav. 2015 Jan;40:45-50. doi: 10.1016/j.addbeh.2014.08.007. Epub 2014 Aug 28.

36.

A history of alcohol dependence augments HIV-associated neurocognitive deficits in persons aged 60 and older.

Gongvatana A, Morgan EE, Iudicello JE, Letendre SL, Grant I, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

J Neurovirol. 2014 Oct;20(5):505-13. doi: 10.1007/s13365-014-0277-z. Epub 2014 Sep 9.

37.

Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioning.

Morgan EE, Doyle KL, Minassian A, Henry BL, Perry W, Marcotte TD, Woods SP, Grant I; Translational Methamphetamine AIDS Research (TMARC) Group.

Psychiatry Res. 2014 Dec 15;220(1-2):527-34. doi: 10.1016/j.psychres.2014.07.008. Epub 2014 Jul 14.

38.

Neurocognitive impairment is associated with lower health literacy among persons living with HIV infection.

Morgan EE, Iudicello JE, Cattie JE, Blackstone K, Grant I, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

AIDS Behav. 2015 Jan;19(1):166-77. doi: 10.1007/s10461-014-0851-7.

39.

Task importance affects event-based prospective memory performance in adults with HIV-associated neurocognitive disorders and HIV-infected young adults with problematic substance use.

Woods SP, Doyle KL, Morgan EE, Naar-King S, Outlaw AY, Nichols SL, Loft S.

J Int Neuropsychol Soc. 2014 Jul;20(6):652-62. doi: 10.1017/S1355617714000435. Epub 2014 May 16.

40.

Shallow encoding and forgetting are associated with dependence in instrumental activities of daily living among older adults living with HIV infection.

Fazeli PL, Doyle KL, Scott JC, Iudicello JE, Casaletto KB, Weber E, Moore DJ, Morgan EE, Grant I, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

Arch Clin Neuropsychol. 2014 May;29(3):278-88. doi: 10.1093/arclin/acu009. Epub 2014 Apr 2.

41.

Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: evidence for a legacy effect?

Iudicello JE, Morgan EE, Gongvatana A, Letendre SL, Grant I, Woods SP; Translational Methamphetamine AIDS Research Center (TMARC) Group.

J Neurovirol. 2014 Feb;20(1):85-98. doi: 10.1007/s13365-014-0233-y. Epub 2014 Jan 28.

42.

"Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency.

Marquine MJ, Iudicello JE, Morgan EE, Brown GG, Letendre SL, Ellis RJ, Deutsch R, Woods SP, Grant I, Heaton RK; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Psychiatry Res. 2014 Jan 30;215(1):208-16. doi: 10.1016/j.psychres.2013.11.004. Epub 2013 Nov 13.

43.

Real-world impact of neurocognitive deficits in acute and early HIV infection.

Doyle KL, Morgan EE, Morris S, Smith DM, Little S, Iudicello JE, Blackstone K, Moore DJ, Grant I, Letendre SL, Woods SP; Translational Methamphetamine AIDS Research Center (TMARC) Group.

J Neurovirol. 2013 Dec;19(6):565-73. doi: 10.1007/s13365-013-0218-2. Epub 2013 Nov 26.

44.

Dual-mixed HIV-1 coreceptor tropism and HIV-associated neurocognitive deficits.

Morris SR, Woods SP, Deutsch R, Little SJ, Wagner G, Morgan EE, Heaton RK, Letendre SL, Grant I, Smith DM.

J Neurovirol. 2013 Oct;19(5):488-94.

45.

Attention-deficit/hyperactivity disorder among chronic methamphetamine users: frequency, persistence, and adverse effects on everyday functioning.

Obermeit LC, Cattie JE, Bolden KA, Marquine MJ, Morgan EE, Franklin DR Jr, Atkinson JH, Grant I, Woods SP; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Addict Behav. 2013 Dec;38(12):2874-8. doi: 10.1016/j.addbeh.2013.08.010. Epub 2013 Aug 19.

46.

Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use.

Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, Franklin DR, Ellis RJ, Grant I, Woods SP; Translational Methamphetamine AIDS Research Center Group.

J Addict Med. 2013 Jul-Aug;7(4):255-63. doi: 10.1097/ADM.0b013e318293653d.

47.

Prospective memory in HIV-associated neurocognitive disorders (HAND): the neuropsychological dynamics of time monitoring.

Doyle KL, Loft S, Morgan EE, Weber E, Cushman C, Johnston E, Grant I, Woods SP; Hiv Neurobehavioral Research Program Hnrp Group.

J Clin Exp Neuropsychol. 2013;35(4):359-72. doi: 10.1080/13803395.2013.776010. Epub 2013 Mar 7.

48.

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.

Morgan EE, Woods SP, Letendre SL, Franklin DR, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Ellis RJ, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, Vaida F, Clifford DB; CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2013 Apr;19(2):150-6. doi: 10.1007/s13365-013-0152-3. Epub 2013 Feb 14.

49.

Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection.

Weber E, Morgan EE, Iudicello JE, Blackstone K, Grant I, Ellis RJ, Letendre SL, Little S, Morris S, Smith DM, Moore DJ, Woods SP; TMARC Group.

J Neurovirol. 2013 Feb;19(1):65-74. doi: 10.1007/s13365-012-0141-y. Epub 2012 Dec 19.

50.

Different roles of the cardiac Na+/Ca2+-exchanger in ouabain-induced inotropy, cell signaling, and hypertrophy.

Bai Y, Morgan EE, Giovannucci DR, Pierre SV, Philipson KD, Askari A, Liu L.

Am J Physiol Heart Circ Physiol. 2013 Feb 1;304(3):H427-35. doi: 10.1152/ajpheart.00462.2012. Epub 2012 Nov 30.

Supplemental Content

Loading ...
Support Center